Table 2.

Clinical outcomes after rebleeding in patients with small bowel angioectasia

	Patients with rebleeding
Number	23
Bleeding pattern (overt/occult)	12/11
Blood transfusion, number (%)	11 (47.8)
Minimum hemoglobin value after rebleeding, g/dl	9.1 ± 2.4
Endoscopic treatment, number (%)	8 (34.8)
Controlled by the end of the follow-up period*, number (%)	18 (78.3)
Iron replacement therapy after rebleeding, number (%)	23 (100)
Hemoglobin value at the end of the follow-up period, g/dl	11.4 ± 2.1

*We defined OGIB as controlled if there was no further overt bleeding within 6 months and the hemoglobin level did not drop below 10 g/dl by the time of the final examination.